Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Cash from Investing Activities (2016 - 2026)

Apyx Medical filings provide 15 years of Cash from Investing Activities readings, the most recent being -$275000.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 12.24% to -$275000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 million, a 54.29% decrease, with the full-year FY2025 number at -$1.1 million, down 54.29% from a year prior.
  • Cash from Investing Activities hit -$275000.0 in Q4 2025 for Apyx Medical, up from -$519000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $7.1 million in Q2 2023 to a low of -$519000.0 in Q3 2025.
  • Median Cash from Investing Activities over the past 5 years was -$181000.0 (2022), compared with a mean of $158250.0.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 1788.89% in 2021 and later soared 1873.32% in 2023.
  • Apyx Medical's Cash from Investing Activities stood at -$332000.0 in 2021, then soared by 57.23% to -$142000.0 in 2022, then skyrocketed by 34.51% to -$93000.0 in 2023, then tumbled by 163.44% to -$245000.0 in 2024, then dropped by 12.24% to -$275000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$275000.0 (Q4 2025), -$519000.0 (Q3 2025), and -$265000.0 (Q2 2025) per Business Quant data.